Article Text

other Versions

PDF
How do the EQ-5D, SF-6D and well-being rating scale compare in patients with ankylosing spondylitis.
  1. Annelies Boonen (aboo{at}sint.azm.nl)
  1. University Hospital Maastricht, Netherlands
    1. Désirée van der Heijde (dhe{at}sint.azm.nl)
    1. University Hospital Maastricht, Netherlands
      1. Robert Landewé (rlan{at}sint.azm.nl)
      1. University Hospital Maastricht, Netherlands
        1. Astrid van Tubergen (avantubergen{at}yahoo.com)
        1. University Hospital Maastricht, Netherlands
          1. Herman Mielants (herman.mielants{at}ugent.be)
          1. Gent University Hospital, Belgium
            1. Maxime Dougados (maxime.dougados{at}cch.ap-hop-paris.fr)
            1. Université Réné Descartes, Hopital Cochin, Paris, France
              1. Sjef van der Linden (sli{at}sint.azm.nl)
              1. University Hospital Maastricht, Netherlands

                Abstract

                Purpose: To compare aspects of validity of EuroQol-5D (EQ-5D) and SF-6D, two indirect utility instruments, and the well-being rating scale (RS) in ankylosing spondylitis (AS).

                Methods: EQ-5D, SF-6D and RS were available for 254 patients fulfilling modified New York criteria. 134 patients were part of an observational cohort and 120 of a randomized controlled trial (RCT). Aspects of validity assessed were truth (agreement and correlation with external health measures) and discrimination (between health states, repeatability and detection of treatment effect).

                Results: Median (range) was 0.69 (-0.08-1.00) for EQ-5D, 0.65 (0.35-0.95) for the SF-6D and 0.65 (0.14- 1.00) for the RS. Agreement (ICC) was moderate (0.46 to 0.55). Instruments correlated equally with disease activity, functioning and quality of life. The SF-6D showed smaller average differences in utility between patients with better and worse disease compared to the EQ-5D and RS. The smallest detectable difference (in control group of RCT) was 0.36, 0.17 and 0.33 for EQ-5D, SF-6D and RS respectively. The ability to detect treatment effect (in intervention group of RCT) showed standardised effect sizes that were moderate for EQ-5D and SF-6D (0.63 and 0.64) and low for the RS (0.23).

                Conclusion: In patients with AS, EQ-5D, SF-6D and the RS correlate equally well with external measures of health but have different psychometric properties. The smallest detectable difference is most favourable for the SF-6D, but it discriminates less well between patients with different disease severity. The RS has worse ability to detect treatment effects. It is difficult to recommend one of the instruments.

                • ankylosing spondylitis
                • health related quality of life
                • quality adjusted life years
                • utility
                • validity

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.